Profession Notes

Breast Cancer Consensus Conference The National Institutes of Health's Office of Medical Applications of Research (OMAR) will hold a consensus conference Nov. 1-3, 2000, on the NIH campus to discuss adjuvant therapies for breast cancer. The first NIH consensus conference on breast cancer therapy in 10 years, it will address the ins and outs of adjuvant radiation, chemotherapy, and hormonal therapy, as well as promising future directions for related research. As with all consensus conferences, he

Eugene Russo
Feb 20, 2000

Breast Cancer Consensus Conference

The National Institutes of Health's Office of Medical Applications of Research (OMAR) will hold a consensus conference Nov. 1-3, 2000, on the NIH campus to discuss adjuvant therapies for breast cancer. The first NIH consensus conference on breast cancer therapy in 10 years, it will address the ins and outs of adjuvant radiation, chemotherapy, and hormonal therapy, as well as promising future directions for related research. As with all consensus conferences, health professionals, researchers, patient advocates, and other members of the public are invited to hear an independent panel of scientists present their findings. Based on the presentations and on public comments, the panel drafts a consensus statement meant to advance the understanding of the issues addressed. To register for the breast cancer conference, send an E-mail to breastcancer@prospectassoc.com or see the NIH Consensus Development Program Web site at odp.od.nih.gov/consensus.

--Eugene Russo

Computational Biology...

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?